Mankind Pharma
Ticker >

Mankind Pharma share price

Mankind Pharma Ltd.

NSE: MANKIND BSE: 543904 SECTOR: Pharmaceuticals & Drugs  76k   226   35

2398.55
+0.25 (0.01%)
NSE: Today, 04:03 PM

Price Summary

Today's High

₹ 2420

Today's Low

₹ 2357.4

52 Week High

₹ 2490

52 Week Low

₹ 1242

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 96083.14 Cr.

Enterprise Value

₹ 95927.99 Cr.

No. of Shares

40.06 Cr.

P/E

58.22

P/B

10.49

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  228.61

CASH

₹ 155.15 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

74.88 %

EPS (TTM)

₹  41.2

Sales Growth

8.56%

ROE

17.43 %

ROCE

21.2%

Profit Growth

-10.16 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.56%
3 Year19.23%
5 Year15.71%

Profit Growth

1 Year-10.16%
3 Year9.21%
5 Year12.45%

ROE%

1 Year17.43%
3 Year22.65%
5 Year22.69%

ROCE %

1 Year21.2%
3 Year29.07%
5 Year29.25%

Debt/Equity

0

Price to Cash Flow

53.41

Interest Cover Ratio

56.3624119705837

CFO/PAT (5 Yr. Avg.)

0.981829882711496

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 74.88 0
Dec 2023 76.51 0
Sep 2023 76.5 0
Jun 2023 76.5 0
Mar 2023 76.5 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 19.234021526329% for the Past 3 years.
  • The company has significantly decreased its debt by 683.6619 Cr.
  • Company has been maintaining healthy ROE of 22.6458826240257% over the past 3 years.
  • Company has been maintaining healthy ROCE of 29.0675389309682% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 56.3624119705837.
  • The Company has been maintaining an effective average operating margins of 22.0675399188538% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -40.2780747748101 days.
  • Company has a healthy liquidity position with current ratio of 2.47604430231229.
  • The company has a high promoter holding of 74.88%.

 Limitations

  • The company has shown a poor profit growth of 9.21406976263837% for the Past 3 years.
  • The company is trading at a high EV/EBITDA of 40.1462.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 1872.12 2300.21 2453.35 2358.57
Total Expenditure 1490.96 1760.74 1818.15 1755.46
Operating Profit 381.16 539.47 635.19 603.11
Other Income 42.46 57.44 58.12 67.23
Interest 0.89 1.97 4.31 4.26
Depreciation 67.3 68.54 77.04 89.73
Exceptional Items 0 0 0 0
Profit Before Tax 355.43 526.39 611.96 576.35
Tax 74.45 117.11 139.08 89.28
Profit After Tax 280.99 409.28 472.89 487.07
Adjusted EPS (Rs) 7.01 10.22 11.8 12.16

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 3829.06 4794.41 5523.18 7486.22 8127.15
Total Expenditure 3124.1 3550.47 4151.05 5647.73 6429.29
Operating Profit 704.96 1243.94 1372.13 1838.49 1697.86
Other Income 64.33 93.85 154.5 203.81 162.78
Interest 39.61 11.1 8.23 47.54 28.23
Depreciation 38.39 61.77 78.19 123.33 269.58
Exceptional Items 0 0 0 0 0
Profit Before Tax 691.3 1264.92 1440.21 1871.44 1562.84
Tax 177.26 306.7 355.83 482.01 314.58
Net Profit 514.04 958.23 1084.37 1389.42 1248.26
Adjusted EPS (Rs.) 12.83 23.92 27.07 34.68 31.16

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 40.06 40.06 40.06 40.06 40.06
Total Reserves 3024.76 3611.39 4694.21 6500.39 7743.85
Borrowings 0 0 0 0 0
Other N/C liabilities 60.6 42.84 54.11 126.98 168.12
Current liabilities 725.15 815.77 1078.91 2271.27 1419.09
Total Liabilities 3850.57 4510.06 5867.29 8938.7 9371.12
Assets
Net Block 767.52 939.25 981.95 2921.3 3136.89
Capital WIP 210.04 143.93 165.51 355.28 437.83
Intangible WIP 1.07 3.69 0.06 31.28 56.95
Investments 1383.85 1389.51 1500.86 1657.08 2040.76
Loans & Advances 92.8 77.6 115.59 146.3 148.86
Other N/C Assets 15.81 10.17 16.04 14.45 36.1
Current Assets 1379.48 1945.9 3087.28 3813.01 3513.72
Total Assets 3850.57 4510.06 5867.29 8938.7 9371.12
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 691.3 1264.92 1440.21 1871.44 1562.84
Adjustment 32.07 137.23 96.74 -4.16 227
Changes in Assets & Liabilities 59.1 -168.42 -156.19 -585.61 294.21
Tax Paid -245.94 -274.12 -397.38 -460.22 -285.06
Operating Cash Flow 536.52 959.61 983.38 821.44 1798.99
Investing Cash Flow -305.58 -395.68 -1127.16 -1360.27 -1040.61
Financing Cash Flow -239.81 -558.91 88.87 578.63 -710.41
Net Cash Flow -8.87 5.02 -54.91 39.81 47.96

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 76.50 76.50 76.50 76.51 74.88
arjun juneja 2.64 2.64 2.64 2.64 2.04
chanakya juneja 0.97 0.97 0.97 0.97 0.97
eklavya juneja 0.97 0.97 0.97 0.97 0.97
mishka arora - 0.74 0.74 0.74 0.74
poonam juneja 2.64 2.64 2.64 2.64 2.64
prem sheetal family trust... 15.42 15.42 15.42 15.42 15.42
puja juneja 3.45 3.45 3.45 3.45 2.88
rajeev juneja 1.62 1.62 1.62 1.62 1.62
rajeev juneja family trus... - 19.95 19.95 19.95 19.95
ramesh juneja 1.71 1.71 1.71 1.71 1.71
ramesh juneja family trus... - 20.81 20.81 20.81 20.81
ria chopra juneja 0.32 0.32 0.32 0.32 0.32
sheetal arora 5.27 5.27 5.27 5.27 4.81
mishka arora 0.74 - - - -
rajeev juneja family trus... 19.95 - - - -
ramesh juneja family trus... 20.81 - - - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 23.50 23.50 23.50 23.49 25.12
axis mutual fund trustee ... - - - - 1.54
hema cipef (i) limited 3.63 3.63 3.63 2.22 2.22
icici prudential mutual f... - - - - 1.60
sbi nifty midcap 150 inde... - - - 1.08 1.52
axis mutual fund trustee ... - - - 1.17 -
beige limited 7.46 7.46 7.46 2.99 -
icici prudential focus eq... - - - 1.50 -
cairnhill cipef limited 1.74 1.74 1.74 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Mankind Pharma Stock Price Analysis and Quick Research Report. Is Mankind Pharma an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Mankind Pharma and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Mankind Pharma cash from the operating activity was Rs 1798.9871 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Mankind Pharma has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Mankind Pharma , the EPS growth was -10.1601287026519 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Mankind Pharma has OPM of 20.8912328612189 % which is a good sign for profitability.
     
  • ROE: Mankind Pharma have a average ROE of 17.4285318016169 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Mankind Pharma is Rs 2398.55. One can use valuation calculators of ticker to know if Mankind Pharma share price is undervalued or overvalued.
Last Updated on:
Brief about Mankind Pharma

Mankind Pharma Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Mankind Pharma Ltd. is a reputed pharmaceutical company that specializes in the development, production, and marketing of high-quality generic medicines. Established in XXXX, the company has since grown to become one of the leading players in the Indian pharmaceutical industry. Mankind Pharma operates with a vision to provide affordable and accessible healthcare solutions to people across the globe.

Mankind Pharma Ltd. - Share Price

Check the latest share price of Mankind Pharma Ltd. and stay updated with real-time market fluctuations. Our pre-built screening tools allow you to track the stock price, monitor trends, and make informed investment decisions.

Mankind Pharma Ltd. - Balance Sheet

The balance sheet of Mankind Pharma Ltd. provides a snapshot of the company's financial position. Analyze the company's assets, liabilities, and equity to gain insights into its overall financial health. We offer premium features such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis to help you calculate fair value.

Mankind Pharma Ltd. - Annual Report

Access the annual reports of Mankind Pharma Ltd. on our website. These reports offer a comprehensive overview of the company's performance, achievements, and future plans. Gain valuable insights into the company's strategies, growth trajectory, and competitive advantage.

Mankind Pharma Ltd. - Dividend

Stay updated with the company's dividend history and payout ratios. Mankind Pharma Ltd. has a track record of consistently rewarding its shareholders through dividends. Our website provides downloadable resources such as dividend history and financial statements for your analysis.

Mankind Pharma Ltd. - Quarterly Result

Get access to the latest quarterly results of Mankind Pharma Ltd. Track the company's revenue, profit, and other key financial metrics to gauge its performance. Our premium features enable you to analyze these results in conjunction with our comprehensive tools for fair value calculation.

Mankind Pharma Ltd. - Stock Price

Monitor the stock price of Mankind Pharma Ltd. and keep track of its historical performance. Our price charts provide a visual representation of the stock's movement over time. Utilize our pre-built screening tools to identify trends, patterns, and potential investment opportunities.

Mankind Pharma Ltd. - News

Stay updated with the latest news and developments related to Mankind Pharma Ltd. Our website provides curated news articles that cover the company's activities, regulatory updates, product launches, and industry trends. Stay informed and make well-informed investment decisions.

Mankind Pharma Ltd. - Concall Transcripts

Access the conference call transcripts of Mankind Pharma Ltd. These transcripts provide a detailed account of the discussions and presentations made during the company's conference calls. Stay informed about management's outlook, strategic initiatives, and future plans.

Mankind Pharma Ltd. - Investor Presentations

Explore the investor presentations of Mankind Pharma Ltd. These presentations offer valuable insights into the company's operations, growth prospects, and market dynamics. Access downloadable resources on our website to stay updated with the latest investor presentations.

Mankind Pharma Ltd. - Promoters

Learn about the promoters of Mankind Pharma Ltd. and their contribution to the company's success. Understand their vision, leadership style, and strategic direction to assess the stability and long-term potential of the company.

Mankind Pharma Ltd. - Shareholders

Discover the major shareholders of Mankind Pharma Ltd. and their significance in the company's ownership structure. Gain insights into the involvement of institutional investors and public shareholders, which play a crucial role in determining the company's governance and market dynamics.

Remember to visit our website for downloadable resources such as annual reports, concall transcripts, investor presentations, credit ratings, and research reports. Our pre-built screening tools and premium features provide you with the necessary tools to analyze and make informed investment decisions.

Read More
X